23 July 2020
“Four vaccines today have proven to be safe, according to Rospotrebnadzor [Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing] and clinical trials on two others are at their final stage. This is the Gamaleya Center and the Defense Ministry. Two [facilities] are also preparing to start trials, these are Vector and the Scientific Research Institute of Vaccines and Serums,” – Russian Prime Minister Mikhail Mishustin told the parliament, the State Duma.
The prime minister stressed that 17 scientific and research institutions in the country were developing the vaccine today, including the Ministry of Education and Science, the Health Ministry, the Federal Medical-Biological Agency and the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. “There are more than 26 types of the vaccine,” Mishustin said.
According to Mishustin, Russia’s healthcare system during the coronavirus pandemic proved that it was ready for challenges. “When I see how doctors and the heads of medical institutions are working, I want to say that it is ready and there is some reserve,” the prime minister said.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024